Nursefriendly.com

Linked In:
http://www.linkedin.com/in/nursefriendly

Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/

http://www.4nursing.com
http://www.legalnursingconsultant.com
http://www.nursinghumor.com
http://www.nursefriendly.com
http://www.nursingcasestudy.com
http://www.nursingentrepreneurs.com
http://www.nursingexperts.com

StumbleUpon,
http://www.nursefriendly.com/stumbleupon
******************************************************

Sincerely,

Andrew Lopez, RN
Nursefriendly, Inc. A New Jersey Corporation.
38 Tattersall Drive, Mantua New Jersey 08051
http://www.nursefriendly.com info@nursefriendly.com ICQ #6116137
856-415-9617, (fax) 415-9618

150,000 + Nurse-Reviewed & Approved Nursing Links

Medical News: Supreme Court Sides With Vaccine Maker - in Washington-Watch, Washington Watch from MedPage Today

The Supreme Court has ruled 6-3 that a federal law shields drug companies from being sued over injuries caused by childhood vaccines.

The case was brought by the parents of Hannah Bruesewitz, now a young adult, and charges that she developed a seizure disorder after receiving her third dose of the diphtheria-tetanus-pertussis (DTP) vaccine when she was 6 months old. She has suffered developmental problems ever since, and will likely require medical attention for the rest of her life, her parents say.

The dose of the vaccine in question, TRI-IMMUNOL, came from a lot that generated 65 reports of adverse reactions, including 39 emergency room visits, six hospitalizations, and two deaths, according to documents from the U.S. appeals court that heard the case in 2009.

The National Childhood Vaccine Injury Act of 1986 created a so-called "vaccine court" to address safety claims in an attempt to ease the threat of lawsuits in state courts against pharmaceutical companies and insure against them pulling out of what they claim is an unprofitable vaccine marketplace completely.

Under the law, people injured by vaccines are eligible for compensation for medical care, rehabilitation, counseling, special education, and vocational training expenses; diminished earning capacity; pain and suffering; and $250,000 for vaccine-related deaths.

via medpagetoday.com

Click on the "via" link to read the rest of the article.

******************************************************
Follow, Connect, Like us on (Most Invites Accepted):

What's New:
http://www.nursefriendly.com/new/

Linked In:
http://www.linkedin.com/in/nursefriendly

Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/

StumbleUpon,
http://www.nursefriendly.com/stumbleupon
******************************************************

Sincerely,

150,000 + Nurse-Reviewed & Approved Nursing Links

Tuesday, February 15, 2011

Obama budget targets brand name medicines, Health.Yahoo.net

Big pharmaceutical companies could face increased competition from generic drugmakers under two proposals put forth by the Obama administration on Monday despite earlier savings extracted from drugmakers as part of last year's healthcare law.

President Barack Obama, as part of his 2012 budget proposal, called for cutting the number of years drugmakers could exclusively market brand-name biologic drugs to 7 years from 12.

He also set his sights on ending controversial "pay-for-delay" deals that affect traditional, chemical drugs by giving the U.S. Federal Trade Commission power to block them. Under such pacts, brand-name and generic drugmakers settle patent challenges with payoffs that delay lower-cost rivals from reaching the market.

The proposals face a tough challenge of getting through the divided Congress, but could alter the landscape for consumers' access to cheaper medicines.

They quickly drew industry protests.

via health.yahoo.net

Any questions, please drop me a line.

******************************************************
Follow us on:

What's New:
http://www.nursefriendly.com/new/

Linked In:
http://www.linkedin.com/in/nursefriendly

Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/

StumbleUpon,
http://www.nursefriendly.com/stumbleupon
******************************************************

Sincerely,

150,000 + Nurse-Reviewed & Approved Nursing Links

Wednesday, November 17, 2010

Grifols USA

Grifols has been working in the fields of transfusion, blood banking and clinical analysis for more than 70 years. Founded in 1940 by Dr. J.A. Grifols Roig, three generations of the Grifols family have led the company ever since. Our Grifols S.A. President, Victor Grifols, ensures that our company will always remain focused on what matters most - people. This dedication to the progress of healthcare for humankind has led to the distribution of Grifols products worldwide.

via alphather.com

Any questions, please drop me a line.

******************************************************
Follow us on:

Linked In:
http://www.linkedin.com/in/nursefriendly

Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/

http://www.4nursing.com
http://www.howtostartanursingagency.com
http://www.jocularity.com
http://www.nursinghumor.com
http://www.nursefriendly.com
http://www.nursingentrepreneurs.com
http://www.nursingexperts.com

StumbleUpon,
http://www.nursefriendly.com/stumbleupon
******************************************************

Sincerely,

150,000 + Nurse-Reviewed & Approved Nursing Links

MedImmune-FluMist

At MedImmune, we seek to develop innovative, high-value products in which we have significant interest, both independently and in collaboration with our partners. By creating cutting-edge biological products, we're improving health, enhancing lives and helping to make a world of difference.

Synagis^® (palivizumab) is the only monoclonal antibody approved by the U.S. Food and Drug Administration (FDA) to help prevent an infectious disease. Synagis is indicated for the prevention of serious lower respiratory tract disease caused by RSV in children at high risk of RSV disease.
MedImmune is dedicated to assisting patients with access to support and resources. To learn more, click here.
To learn more about Synagis, click here for Important Safety & Prescribing Information.

Approved Synagis Distribution Network Members
Approved Physician Purchase Channel Distributors

Wholesale Accounts
AmerisourceBergen
Cardinal
H.D. Smith
McKesson
Morris Dickson

FluMist^® (Influenza Vaccine Live, Intranasal) is the first and only nasal spray flu vaccine approved in the United States to help prevent influenza and is indicated for the active immunization of eligible individuals 2 to 49 years of age against influenza disease caused by influenza virus subtypes A and B contained in the vaccine.

via medimmune.com

Any questions, please drop me a line.

******************************************************
Follow us on:

Linked In:
http://www.linkedin.com/in/nursefriendly

Nursing Entrepreneurs, Nurses In Business
http://nursingentrepreneurs.ning.com/